Recent News

• 11.05.2026 - FocalTherics™ Reports Third Quarter 2026 Financial Results
• 11.04.2026 - FocalTherics™ to Participate in Upcoming Investor Conferences
• 10.22.2026 - FocalTherics™ to Announce Third Quarter 2026 Financial Results on November 5, 2026
• 09.01.2026 - FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference
• 08.13.2026 - FocalTherics™ Reports Second Quarter 2026 Financial Results
• 08.12.2026 - FocalTherics™ Announces Pricing of Public Offering of American Depositary Shares
• 08.11.2026 - FocalTherics™ Reports Preliminary Financial Results for Second Quarter of 2026
• 08.11.2026 - FocalTherics™ Announces Proposed Public Offering of American Depositary Shares
• 07.30.2026 - FocalTherics™ to Announce Second Quarter 2026 Financial Results on August 13, 2026
• 06.30.2026 - FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients

Recent Filings

• 11.05.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.05.2026 - 8-K Current report
• 11.05.2026 - EX-99.1 EX-99.1
• 10.19.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 09.15.2026 - S-8 Securities to be offered to employees in employee benefit plans
• 08.20.2026 - 3 Initial statement of beneficial ownership of securities
• 08.19.2026 - 8-K Current report
• 08.17.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.17.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.17.2026 - 4 Statement of changes in beneficial ownership of securities